InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（11 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
11
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Friedl-Naderer Johanna, Directeur Commercial. Officer active across 2 companies, notably Dyne Therapeutics, Inc.. In total, 16 filings have been published. Split: 0 buy · 11 sells. Total volume traded: €80k. History available since 2 March 2022. The latest transaction was filed on 4 September 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Friedl-Naderer Johanna
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
900 股@ US$24.35Common StockSEC:0001915598-26-000005:0
185 股@ US$18.88Common StockSEC:0001915598-26-000005:1
226 股@ US$26.280.0001% mcap19.3% 占其流量Common StockSEC:0001915598-26-000004:0
145 股Common StockSEC:0001915598-26-000002:0
228 股@ US$18.360.0001% mcap50.0% 占其流量Common StockSEC:0001193125-26-223984:0
148 股@ US$14.908.8% 占其流量Common StockSEC:0001193125-26-096523:0
60,000 股0Common StockSEC:0001193125-26-055063:0
144 股@ US$20.7213.1% 占其流量Common StockSEC:0001193125-25-309636:0
894 股@ US$13.2759.7% 占其流量Common StockSEC:0000950170-25-113545:0
146 股@ US$13.3524.8% 占其流量Common StockSEC:0000950170-25-083033:0
143 股@ US$12.1218.2% 占其流量Common StockSEC:0000950170-25-038750:0
37,800 股0Common StockSEC:0000950170-24-134078:0
58,400 股0Common StockSEC:0000950170-24-103033:0
1,482 股@ US$22.82100.0% 占其流量Common StockSEC:0001209191-23-016629:0
60,000 股0Common StockSEC:0001209191-23-012991:0
90,000 股0Common StockSEC:0001209191-22-016929:0
16 条申报中的 16 条
About Friedl-Naderer Johanna
Friedl-Naderer Johanna is Director Commercial and has disclosed 13 transactions in total. In the recent filings available, these relate to sales between 2022-03-08 and 2026-06-17, for total sales of EUR 53407, with transactions reported in Vir Biotechnology, Inc. and Dyne Therapeutics, Inc.
